Warnatz, Klaus 1964-
Klaus Warnatz researcher
VIAF ID: 57294189 (Personal)
Permalink: http://viaf.org/viaf/57294189
Preferred Forms
- 100 0 _ ‡a Klaus Warnatz ‡c researcher
- 100 1 _ ‡a Warnatz, Klaus ‡d 1964-
- 100 1 _ ‡a Warnatz, Klaus ‡d 1964-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
14 years after discovery : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency | |
IL-21 restricts T follicular regulatory T cell proliferation through Bcl-6 mediated inhibition of responsiveness to IL-2 | |
ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial | |
Advances in the care of primary immunodeficiencies (PIDs): from birth to adulthood | |
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade | |
Analysis of granulomatous lymphocytic interstitial lung disease using two scoring systems for computed tomography scans - a retrospective cohort study | |
antigen presenting potential of CD21low B cells | |
Assessing the functional relevance of variants in the IKAROS family zinc finger protein 1 (IKZF1) in a cohort of patients with primary immunodeficiency | |
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency | |
Autoreactive antibodies control blood glucose by regulating insulin homeostasis | |
B-cell homeostasis in health and disease = B-Zell-Homöostase im Gesunden und Kranken | |
Bronchoalveolar lavage fluid reflects a TH1-CD21low B-cell interaction in CVID-related interstitial lung disease | |
Case report: Hemophagocytic lymphohistiocytosis and non-tuberculous mycobacteriosis caused by a novel GATA2 variant | |
Case series: convalescent plasma therapy for patients with COVID-19 and primary antibody deficiency | |
Charakterisierung einer übertragbaren enzymatischen Resistenz gegen Cephalosporine der dritten Generation SHV Aachen | |
Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2 | |
Curation and expansion of human phenotype ontology for defined groups of inborn errors of immunity | |
CVID-associated B cell activating factor receptor variants change receptor oligomerization, ligand binding, and signaling responses | |
Deep phenotyping of CD11c+ B cells in systemic autoimmunity and controls | |
Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50 | |
Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase [delta] syndrome: the european society for immunodeficiencies-activated phosphoinositide 3-kinase [delta] syndrome registry | |
Disease progression of WHIM syndrome in an international cohort of 66 pediatric and adult patients | |
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS | |
Distinct CD8 T cell populations with differential exhaustion profiles associate with secondary complications in common variable immunodeficiency | |
Dysregulated PI3K signaling in B cells of CVID patients | |
Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies | |
Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT | |
Editorial: Updates on the pathogenesis of common variable immunodeficiency (CVID) | |
Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study | |
Evaluation of laboratory and sonographic parameters for detection of portal hypertension in patients with common variable immunodeficiency | |
Follicular helper T cells in diGeorge syndrome | |
GAIN Registry - a new prospective study for patients with multi-organ autoimmunity and autoinflammation | |
Genomic characterization of lymphomas in patients with inborn errors of immunity | |
German national registry of primary immunodeficiencies (2012–2017) | |
Germline deletion of CIN85 in humans with X chromosome – linked antibody deficiency | |
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) | |
GVHD, IBD and primary immunodeficiencies: the gut as a target of immunopathology resulting from impaired immunity | |
Immunrekonstitution nach allogener Stammzelltransplantation | |
Increased risk for malignancies in 131 affected CTLA4 mutation carriers | |
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome | |
Is it safe to switch from intravenous immunoglobulin to subcutaneous immunoglobulin in patients with common variable immunodeficiency and autoimmune thrombocytopenia? | |
Kostimulatorische Kapazität von CD21low B-Zellen bei Patienten mit Autoimmunerkrankungen | |
Lymphoid stromal cells - potential implications for the pathogenesis of CVID | |
Makrozytäre Anämie und Polychondritis: VEXAS-Syndrom | |
Managing granulomatous–lymphocytic interstitial lung disease in common variable immunodeficiency disorders: e-GLILDnet International Clinicians Survey | |
Mechanisms of CD8+ T cell failure in chronic hepatitis E virus infection | |
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction | |
Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI | |
Novel insights into the role of BAFFR and CVID-associated BAFFR variants | |
Observation and long-term follow-up of patients with isolated hypogammaglobulinaemia at the Royal Free Hospital, London | |
Outcome of chronic granulomatous disease ‐ conventional treatment vs stem cell transplantation | |
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients | |
Phenotypic and functional comparison of class switch recombination deficiencies with a subgroup of common variable immunodeficiencies | |
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases | |
Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2 | |
Räumliche Darstellung der Keimzentrumsvaskulatur und ihr Bezug zu den Keimzentrumsplasmazellen | |
Rolle der Ficoline bei Patienten mit variablem Immundefekt (CVID) | |
Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group: Screening respiratory status in PID | |
Sequencing the B cell receptor repertoires of antibody-deficient individuals with and without infection susceptibility | |
Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses | |
Subklinische Infektionen des Respirationstraktes bei CVID | |
Targeted proteomics reveals inflammatory pathways that classify immune dysregulation in common variable immunodeficiency | |
A toolkit for monitoring immunoglobulin G levels from dried blood spots of patients with primary immunodeficiencies | |
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient | |
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes | |
Treatment and management of primary antibody deficiency: German interdisciplinary evidence‐based consensus guideline | |
Treatment strategies for GLILD in common variable immunodeficiency: a systematic review |